
Summit Therapeutics Inc.
USD14.52
+0.20 (+1.40%)
CEO
Robert W. Duggan
IPO Date
2015-03-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$14.32
Prev. Close
$14.32
Day Low
$14.31
Day High
$14.89
52W Low
$12.55
52W High
$30.98
Market Cap
$11.27B
Volume
3.01M
| 8 Apr 2026 |
| Stifel |
| Buy |
| Buy |
| maintain |
| 16 Mar 2026 | Jefferies | Buy | Hold | downgrade |
| 24 Feb 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 2 Feb 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 30 Jan 2026 | Citizens | Market Outperform | Market Outperform | maintain |
| 17 Dec 2025 | Barclays | Underweight | Equal Weight | upgrade |
| 22 Oct 2025 | Guggenheim | Buy | Buy | maintain |